DNMT3A and acute lymphoblastic leukemia: By analyzing Oncomine data derived from Haferlach et al., [23] we determined that DNMT1, DNMT3A and DNMT3B mRNA expression levels are elevated in clinical T-ALL compared to non-malignant cells (Figure 2A).